✦ LIBER ✦

P.3.a.026 Safety, tolerability and D2 occupancy of the fast dissociating D2 antagonist JNJ-37822681 in healthy subjects

✍ Scribed by M. Schmidt; P. de Boer; E. Mannaert; T. Iersel; L. van Nueten

Book ID: 118597306
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 45 KB
Volume: 20
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(10)70646-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.c.046 Efficacy and safety of JNJ 378

P.3.c.046 Efficacy and safety of JNJ 37822681, a fast dissociating D2 receptor antagonist, in the treatment of schizophrenia

✍ M. Schmidt; L. Janssens; J. Kent; I. Anghelescu; G. Hüsken; V. Sinha; E. Mannaer 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Pharmacology of JNJ-37822681, a Specific

Pharmacology of JNJ-37822681, a Specific and Fast-Dissociating D2 Antagonist for the Treatment of Schizophrenia

✍ Langlois, X.; Megens, A.; Lavreysen, H.; Atack, J.; Cik, M.; te Riele, P.; Peete 📂 Article 📅 2012 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 611 KB

P.3.d.009 Pharmacology of JNJ-37822681,

P.3.d.009 Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophrenia

✍ X. Langlois; A. Megens; H. Lavreysen; R. Wouters; L. Peeters; P. te Riele; H. He 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

D2-receptor occupancy measurement of JNJ

D2-receptor occupancy measurement of JNJ-37822681, a novel fast off-rate D2-receptor antagonist, in healthy subjects using positron emission tomography: single dose versus steady state and dose selection

✍ Mark E. Schmidt, Peter de Boer, Randolph Andrews, Martine Neyens… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 277 KB

P01-79 - Pet-measured occupancy of the D

P01-79 - Pet-measured occupancy of the D2 receptor: a comparison of quetiapine fumarate immediate-and extended-release formulations in healthy subjects

✍ S. Nyberg 📂 Article 📅 2010 🏛 Elsevier Science 🌐 French ⚖ 27 KB

In vivo evaluation of the oral absorptio

In vivo evaluation of the oral absorption and GI transit of avitriptan in fed and fasted subjects using gamma scintigraphy: P.H. Marathe1, E.P. Sandefer2, G.E. Kollia2, D.S. Greene1, R.H. Barbhaiya1, R.A. Lipper2, R.C. Page2, W.J. Doll3, U.Y. Ryo2, and G.A. Digenis2 1 Bristol-Myers Squibb Company, Princeton NJ; 2 University of Kentucky, Lexington, KY; 3 Scintipharma, Inc., Lexington, KY

📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 154 KB